Hybrid Macrocyclic Peptides — Synthetic Strategies to Diversify and Cyclize Peptide Libraries in Phage Display Selections
Chemistry – A European Journal · 2026
DOI: 10.1002/chem.71408 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chemistry – A European Journal, 2026. Verfasst von Titia Rixt Oppewal und 1 weiteren Autor:innen. Beteiligte Einrichtung: Stratingh Institute for Chemistry, University of Groningen, Groningen, The Netherlands. Hauptthemen laut MEDLINE: Peptide Library, Peptides, Cyclic, Macrocyclic Compounds, Peptides. Die Arbeit nennt 225 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NWO, ERC, Nederlandse Organisatie voor Wetenschappelijk Onderzoek.
Abstract (Originalsprache)
Macrocyclic peptides (MPs) are privileged molecular architectures in drug discovery that combine the target selectivity of biologics with the pharmacological advantages of small molecules. However, peptide binders identified by biological selection platforms such as bacteriophage display often require extensive post‐selection medicinal chemistry optimization before entering the clinic. In particular, the incorporation of nonpeptidic scaffolds and synthetic cyclization units is frequently necessary to improve binding affinity, proteolytic stability, membrane permeability, and overall pharmacological performance. In this Review, we provide a comprehensive overview and critical analysis of strategies that enable the direct selection of such hybrid MPs by bacteriophage display. We discuss established cysteine‐ and lysine‐targeting chemistries, recent advances in residue‐selective and chemoenzymatic cyclization methods, and emerging approaches that exploit proximity‐driven reactivity or the chemical sturdiness of bacteriophages. Collectively, these strategies enable the simultaneous exploration of peptide sequence and synthetic chemical space during biological selections, thereby potentially reducing downstream optimization efforts. Finally, we outline key design principles for phage‐compatible macrocyclization reactions and discuss future opportunities at the interface of bioconjugation chemistry, enzyme engineering, and machine‐learning‐guided peptide discovery to accelerate the development of next‐generation peptide therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Stratingh Institute for Chemistry, University of Groningen, Groningen, The Netherlands.
ORCID-Profile: Titia Rixt Oppewal, Clemens Mayer
Förderung
- NWO
- ERC
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- European Research Council
Zitieren
APA
Oppewal, T. R., & Mayer, C. (2026). Hybrid Macrocyclic Peptides — Synthetic Strategies to Diversify and Cyclize Peptide Libraries in Phage Display Selections. Chemistry – A European Journal. https://doi.org/10.1002/chem.71408
Vancouver
Oppewal TR, Mayer C. Hybrid Macrocyclic Peptides — Synthetic Strategies to Diversify and Cyclize Peptide Libraries in Phage Display Selections. Chemistry – A European Journal. 2026. doi:10.1002/chem.71408
BibTeX
@article{Oppewal2026,
author = {Oppewal, Titia Rixt and Mayer, Clemens},
title = {Hybrid Macrocyclic Peptides — Synthetic Strategies to Diversify and Cyclize Peptide Libraries in Phage Display Selections},
journal = {Chemistry – A European Journal},
year = {2026},
doi = {10.1002/chem.71408}
}
EUVIMED